Insights | Research Blogs | Lambda Therapeutic Research

Home
/
Lambda Insights
/
Research Blogs

Research Blogs

Blog

Study Insights: Phase-I, Bioequivalence Study of Trastuzumab SC Injection

Blog

Specialized Clinical Development Support for Semaglutide Programs

BlogClinical Research

Full-Service CRO | End-to-End Expertise for Every Phase of Clinical Development

BlogLabs

Study Insights: Bioequivalence Study of Semaglutide Injection 1.34 mg/ml (2 mg/1.5 mL)

BlogLate Phase

Ovarian Cancer Clinical Trials – Advancing Research Through Patient-Focused Approaches

BlogLate Phase

Strategic Endpoint Selection for Successful Oncology Clinical Trials

BlogClinical Research

Navigating CDSCO Regulations: Key Approval Processes and Lambda’s Regulatory Support

BlogLate Phase

Advancing Clinical Development in Women’s Health

BlogLabs

A Highly Precise, Accurate, and Robust LC-MS/MS Method for the Quantification of Semaglutide in Human Plasma

BlogLate Phase

Patient-Centric Trials in Advancing Cancer Research: A Journey of Progress & Hope

BlogPharmacovigilance

Ensuring Drug Safety: Lambda’s Pharmacovigilance Milestones in 2024

BlogEarly Phase

Nutraceuticals and Consumer Products Studies: Ensure product safety & efficacy with expert-led trials

BlogLate Phase

Advancing Prostate Cancer Clinical Trials: Key Insights

BlogLabs

Summation of Similar Product Ions for Improved LC-MS-MS Quantitation: Advancing Peptide Analysis

BlogClinical Research

What are Clinical Trials? Unlocking the Basics and the Critical Importance

BlogLate Phase

Advancing Lung Cancer Clinical Trials

BlogPharmacovigilance

Efficient ICSR Management and Regulatory Compliance for Bulk Case Handling

BlogLate Phase

Breast Cancer Clinical Trials – Transforming Lives Through Patient-Centric Trials

BlogPharmacovigilance

Ensuring PV Quality Assurance: A Comprehensive Approach

BlogMedical Affairs

From Complexity to Clarity: Ensuring Seamless Regulatory Submissions Through Expert Medical Writing

Let's Unveil New Therapies Together

Connect with our experts to leverage our proven track record of clinical research excellence.